Giverny Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-432
Closed -$140K 67
2022
Q3
$140K Hold
432
0.01% 60
2022
Q2
$140K Hold
432
0.01% 60
2022
Q1
$124K Hold
432
0.01% 61
2021
Q4
$119K Hold
432
0.01% 62
2021
Q3
$100K Hold
432
0.01% 57
2021
Q2
$99K Hold
432
0.01% 55
2021
Q1
$81K Hold
432
0.01% 52
2020
Q4
$73K Hold
432
0.01% 53
2020
Q3
$64K Buy
+432
New +$66.9K 0.01% 53

Other funds holding LLY

Giverny Capital's LLY Position: Q4 2022 in Review

Giverny Capital sold out of Eli Lilly (LLY) in Q4 2022, closing a stake of 432 shares — an estimated $140K sold.

Giverny Capital first reported a position in LLY in Q3 2020 and held it in 9 quarters. The position peaked at $140K in Q3 2022. 2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

  • Giverny Capital reported no remaining Eli Lilly position as of Q4 2022 after selling out during the quarter.
  • Giverny Capital sold 432 Eli Lilly shares in Q4 2022, an estimated $140K.
  • Giverny Capital first reported a position in Eli Lilly in Q3 2020 and held it in 9 quarters.
  • Giverny Capital's Eli Lilly position peaked at $140K in Q3 2022.
  • 2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on Giverny Capital's 13F filing for Q4 2022, filed 10 Feb 2023.